1. Home
  2. SXTP

SXTP

60 Degrees Pharmaceuticals Inc.

Logo 60 Degrees Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Founded: 2010 Country:
United States
United States
Employees: N/A City: WASHINGTON
Market Cap: 3.0M IPO Year: 2023
Target Price: $2.40 AVG Volume (30 days): 349.8K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.99 EPS Growth: N/A
52 Week Low/High: $0.22 - $8.65 Next Earning Date: 05-05-2024
Revenue: $253,573 Revenue Growth: -50.40%
Revenue Growth (this year): 316.05% Revenue Growth (next year): 267.77%

Share on Social Networks: